Complete report $4,600. DataPack (test volumes, sales forecasts, supplier shares) $2, 900.
This new 282-page report from Venture Planning Group provides analysis of the US respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
About this Report
This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales forecasts and market segment, including:
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test. Also, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen
- Reviews features and operating characteristics of major analyzers used
for respiratory disease testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Groups proprietary data files was conducted.
Contains 282 pages and 23 tables
SIMILAR MARKET STUDIES
This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.
November 2014 | $0 | View Details >>
This new report from VPGMarketResearch.com contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including:
October 2015 | $2900 | View Details >>
2016 Future Horizons and Growth Strategies in the US Virology and Bacteriology Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities by Test
Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative ...
November 2015 | $6400 | View Details >>
2017 Indonesia Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests-Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares features of leading analyzers; profiles key competitors; ...
January 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research